Santhera annonce aujourd'hui l'extension de son accord de distribution exclusif avec Biomedica pour AGAMREE (vamorolone), \u00e9tendant le partenariat \u00e0 la G\u00e9orgie, au Kazakhstan, \u00e0 la Bi\u00e9lorussie, \u00e0 l'Azerba\u00efdjan et \u00e0 l'Ouzb\u00e9kistan, pour le traitement de la dystrophie musculaire de Duchenne (DMD) chez les patients \u00e2g\u00e9s de deux ans et plus.<\/p>\n\n\n\n
Initialement d\u00e9sign\u00e9 distributeur d'AGAMREE\u00ae en octobre 2025, Biomedica, aux termes de l'accord \u00e9largi, sera d\u00e9sormais responsable de la distribution sur cinq march\u00e9s suppl\u00e9mentaires. Santhera continuera de percevoir un pourcentage des ventes nettes, conform\u00e9ment aux termes de l'accord initial. Environ 2\u00a0000 patients atteints de DMD vivent dans ces pays, o\u00f9 les options th\u00e9rapeutiques se limitaient jusqu'\u00e0 pr\u00e9sent aux corticost\u00e9ro\u00efdes classiques. Cet accord \u00e9largi permettra \u00e0 ces patients d'acc\u00e9der \u00e0 AGAMREE\u00ae. En savoir plus\u00a0: Qu'est-ce que AGAMERE (Vamorolone)\u00a0?<\/a><\/p>\n\n\n\n <\/p>","protected":false},"excerpt":{"rendered":" Santhera today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, for the treatment of Duchenne muscular dystrophy (DMD) in patients two years of age and older. Biomedica was originally appointed as a distributor for AGAMREE\u00ae in October 2025. Under […]<\/p>\n","protected":false},"author":1,"featured_media":8252,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,846,845,433,843,844,41,43],"class_list":["post-8251","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-azerbaijan","tag-belarus","tag-biomedica","tag-georgia","tag-kazakhstan","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/8251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=8251"}],"version-history":[{"count":1,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/8251\/revisions"}],"predecessor-version":[{"id":8253,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/8251\/revisions\/8253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/8252"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=8251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=8251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=8251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}